Progress in Mind Portugal

Topics
Congress highlights
- EAN 2022
- AAN 2022
- AHS 2022
- AAN 2021
- AHS 2021
- IHC 2021
- SIRS 2019
- EPA 2019
- EPA 2018
- APA 2018
- ECNP 2017
About
Podcasts
Newsletter signup

Search

Main navigation

Home
Lundbeck Therapeutic Area Australia
Progress in Mind Korea Focus Area
Progress in Mind Spain Focus Area
전문가 칼럼
찾아보기

Tools

찾아보기
User Profile

User account menu

Log in

Username

Password

Reset your password

Powered by Drupal

Search

The information on this site is exclusively intented for health care professionals.

Accept Decline

Aeitology

Migraine 29 Oct, 2021 Read Time: 4 mins

Congress highlights

Do anti-CGRP monoclonal antibodies alter the expected course of migraine?

Are anti-CGRP monoclonal antibodies disease modifying therapies for migraine? Do they alter the...
Bipolar, Schizophrenia 26 Oct, 2021 Read Time: 2 mins

Congress highlights

Do similar polygenic risk factors for schizophrenia apply across ethnic groups?

Polygenic risk factors for schizophrenia and bipolar disorder-- and the genetic factors that...
Schizophrenia 04 Oct, 2021 Read Time: 4 mins

Satellite symposium

Small steps for big impact in treatment of schizophrenia

Functional recovery is an important goal in treating schizophrenia, but one that can be hard to...
Mental Health 02 Oct, 2021 Read Time: 3 mins

Congress highlights

Highlights from ECNP 2021 — Day 4 — October 5th

Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
Schizophrenia 02 Oct, 2021 Read Time: 4 mins

Satellite symposium

Bridging treatment adherence to functional recovery in schizophrenia

Non-adherence to treatment is a key issue in people with schizophrenia and can hold back response,...
Schizophrenia 02 Oct, 2021 Read Time: 4 mins

Satellite symposium

Bridging treatment adherence to functional recovery in schizophrenia

Non-adherence to treatment is a key issue in people with schizophrenia and can hold back response,...
Migraine 13 Sep, 2021 Read Time: 3 mins

Satellite symposium

Anti-CGRP monoclonal antibodies in the real world

When are anti-CGRP monoclonal antibodies used for migraine in the real world, how effective are they,...
Schizophrenia 13 Sep, 2021 Read Time: 3 mins

Congress highlights

Cytokine dysregulation in schizophrenia

Studies continue to indicate a multifaceted relationship between immunological and inflammatory...